EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS)
Clinical trials for EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare gut disease: dupilumab trial launches
Disease control Recruiting nowThis study is testing the drug dupilumab in 20 children whose eosinophilic gastrointestinal disorders have not responded to other treatments. The goal is to see if dupilumab can heal ulcers and reduce inflammation in the stomach and gut. Children receive injections every one or t…
Matched conditions: EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS)
Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Scientists seek better yardsticks for rare gut diseases
Knowledge-focused Recruiting nowThis study is looking at people with eosinophilic gastrointestinal disorders, which cause inflammation in the gut. Researchers want to see if simple questionnaires can tell how well a patient is doing, compared to looking at tissue samples from endoscopies. The goal is to find be…
Matched conditions: EOSINOPHILIC GASTROINTESTINAL DISORDERS (EGIDS)
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:52 UTC